Lorraine Davis
PhD Student, Cancer Biology Program
Lorraine’s research is focused on studying mechanisms of drug resistance in myeloma, particularly acquired resistance to immunomodulatory drugs (IMiDs). She has established an intracellular protein flow cytometry-based platform to measure the downstream
effects of IMiDs in multiple myeloma patient samples to classify how resistance occurs. Lorraine graduated from Seattle University in Cell and Molecular Biology with a minor in Chemistry. Her undergraduate research projects involved the structural/functional
characterization of DNA recognition and cleavage specificity in homing endonucleases and developing a next-generation sequencing platform to study how human land use impacts urban carnivores. She also worked as an intern at Seattle Genetics in quantitative
pharmacology of antibody-drug conjugates. After graduation, Lorraine joined the Cancer Biology PhD program at CU.
Outside the lab, she enjoys painting and drawing, outdoor water activities, and spending time with friends and family.